Similar Items: Design and development of novel irreversible GSK-3β inhibitors to address Alzheimer's disease
- Design, synthesis and biological activity studies of 1-aryl-3-(4-methoxybenzyl)ureas as proposed irreversible GSK-3 inhibitors in Alzheimer’s disease therapeutic development
- Design and synthesis of benzazole ureas as proposed irreversible GSK-3β inhibitors
- Design and synthesis of Covalent Kinase Inhibitors Utilising Novel Electrophiles
- In vitro effect of selected medicinal plants on β-amyloid induced toxicity in neuroblastoma cells
- Selective GSK3β inhibition mediates an Nrf2-independent anti-inflammatory microglial response
- Role of glycogen synthase kinase 3 (GSK-3) and its substrate proteins in the development of cardiomyopathy associated with obesity and insulin resistance
Author: Blackie, Margaret A. L.
- Synthesis and biological evaluation of novel ferroquine and phenylequine analogues
- Investigating the formation of multicomponent crystals of antiplasmodial agents
- Synthesis of fused heterocyclic aromatic compounds as potential antiplasmodial agents
- Design and synthesis of dual-active heterocyclic yybrid inhibitors for β-Hematin and plasmodium falciparum N-Myristoyltransferase
- Towards knower awareness in chemistry and chemistry education
- Design and development of novel irreversible GSK-3β inhibitors to address Alzheimer's disease